Utility of D-dimer testing in patients with clinically suspected pulmonary embolism and elevated C-reactive protein levels

 

^* These authors contributed equally.

• References

• 1 van Belle A, Büller HR, Huisman MV. et al. Christopher Study Investigators. Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. J Am Med Assoc 2006; 295: 172-179.
• 2 Goekoop RJ, Steeghs N, Niessen RW. et al. Simple and safe exclusion of pulmonary embolism in outpatients using quantitative D-dimer and Wells' simplified decision rule. Thromb Haemost 2007; 97: 146-150.
• 3 Kelly J, Rudd A, Lewis RR. et al. Plasma D-dimers in the diagnosis of venous thromboembolism. Arch Intern Med 2002; 162: 747-756.
• 4 Kovacs MJ, MacKinnon KM, Anderson D. et al. A comparison of three rapid D-dimer methods for the diagnosis of venous thromboembolism. Br J Haematol 2001; 115: 140-144.
• 5 Gaffney PJ, Creighton LJ, Callus MJ. et al. Monoclonal antibodies to crosslinked fibrin degradation products (XL-FDP). II Evolution in a variety of clinical conditions. Br J Haematol 1988; 68: 91-96.
• 6 Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999; 340: 448-454.
• 7 Rylatt DB, Blake AS, Cottis LE. et al. An immunoassay for human D-Dimer using monoclonal antibodies. Thromb Res 1983; 31: 767-778.
• 8 Wells PS, Anderson DR, Rodger M. et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with simpliRED D-dimer. Thromb Haemost 2000; 83: 416-420.